EUVIMEDEUVIMED entdecken
Übersichtsarbeit

An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management

Caroline Assunção Oliveira, Érika Azenathe Barros Mercês, Fernanda Santos Portela, Lara Fabiana Luz Malheiro, Henrique Bruno Lopes Silva, Laís Mafra De Benedictis, Júlia Mafra De Benedictis, Clara Cotta d'Ávilla E Silva, Alberto Christian Luz Santos, Dã Pinheiro Rosa, Helloisa Souza Velozo, Telma de Jesus Soares und 1 weitere

Clinical and Experimental Nephrology · 2024-08 · 28 (8) · 711-727

DOI: 10.1007/s10157-024-02490-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Experimental Nephrology, online erschienen am 27.04.2024. Verfasst von Caroline Assunção Oliveira und 12 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Bahia, 45029-094, Brazil. Hauptthemen laut MEDLINE: Cisplatin, Cardiotoxicity, Antineoplastic Agents, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 184 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado da Bahia, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin (CP) is a chemotherapy drug widely prescribed to treat various neoplasms. Although fundamental for the therapeutic action of the drug, its cytotoxic mechanisms trigger adverse effects in several tissues, such as the kidney, liver, and heart, which limit its clinical use. In this sense, studies point to an essential role of damage to nuclear and mitochondrial DNA associated with oxidative stress, inflammation, and apoptosis in the pathophysiology of tissue injuries. Due to the limitation of effective preventive and therapeutic measures against CP-induced toxicity, new strategies with potential cytoprotective effects have been studied. Therefore, this article is timely in reviewing the characteristics and main molecular mechanisms common to renal, hepatic, and cardiac toxicity previously described, in addition to addressing the main validated strategies for the current management of these adverse events in clinical practice. We also handle the main promising antioxidant substances recently presented in the literature to encourage the development of new research that consolidates their potential preventive and therapeutic effects against CP-induced cytotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinCardiotoxicityAntineoplastic AgentsChemical and Drug Induced Liver InjuryHumansKidney DiseasesAnimalsOxidative StressAntioxidantsKidneyHeart Diseases

Stichwörter der Autor:innen

Adverse effectsCisplatinCytotoxicityPathophysiological mechanismsTherapeutic approaches

Substanzen

CisplatinAntineoplastic AgentsAntioxidants

Autor:innen und Institutionen

  • Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Bahia, 45029-094, Brazil.
  • Programa de Pós-Graduação Multicêntrico em Ciências Fisiológicas, Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Bahia, 45029-094, Brazil.
  • Programa de Pós-Graduação em Biociências, Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Bahia, 45029-094, Brazil.
  • Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Bahia, 45029-094, Brazil. liliany.amaral@ufba.br.
  • Programa de Pós-Graduação Multicêntrico em Ciências Fisiológicas, Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Bahia, 45029-094, Brazil. liliany.amaral@ufba.br.
  • Programa de Pós-Graduação em Biociências, Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Bahia, 45029-094, Brazil. liliany.amaral@ufba.br.

Förderung

  • Fundação de Amparo à Pesquisa do Estado da Bahia
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Oliveira, C. A., Mercês, É. A. B., Portela, F. S., Malheiro, L. F. L., Silva, H. B. L., De Benedictis, L. M., De Benedictis, J. M., Silva, C. C. D. E., Santos, A. C. L., Rosa, D. P., Velozo, H. S., de Jesus Soares, T., & de Brito Amaral, L. S. (2024). An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management. Clinical and Experimental Nephrology, 28(8), 711-727. https://doi.org/10.1007/s10157-024-02490-x

Vancouver

Oliveira CA, Mercês ÉAB, Portela FS, Malheiro LFL, Silva HBL, De Benedictis LM, et al. An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management. Clinical and Experimental Nephrology. 2024;28(8):711-727. doi:10.1007/s10157-024-02490-x

BibTeX
@article{Oliveira2024,
  author = {Oliveira, Caroline Assunção and Mercês, Érika Azenathe Barros and Portela, Fernanda Santos and Malheiro, Lara Fabiana Luz and Silva, Henrique Bruno Lopes and De Benedictis, Laís Mafra and De Benedictis, Júlia Mafra and Silva, Clara Cotta d'Ávilla E and Santos, Alberto Christian Luz and Rosa, Dã Pinheiro and Velozo, Helloisa Souza and de Jesus Soares, Telma and de Brito Amaral, Liliany Souza},
  title = {An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management},
  journal = {Clinical and Experimental Nephrology},
  year = {2024},
  volume = {28},
  number = {8},
  pages = {711--727},
  doi = {10.1007/s10157-024-02490-x}
}
Kostenlos starten →